Alpine Immune Sciences Inc ALPN:NASDAQ

RT Quote | Last NYSE, VOL From CTA | USD
Last | 2:03 PM EDT
64.58quote price arrow up+0.03 (+0.05%)
Volume
804,250
52 week range
6.71 - 64.70
Loading...
  • Open64.57
  • Day High64.63
  • Day Low64.56
  • Prev Close64.55
  • 52 Week High64.70
  • 52 Week High Date04/23/24
  • 52 Week Low6.71
  • 52 Week Low Date05/04/23

Key Stats

  • Market Cap4.233B
  • Shares Out65.55M
  • 10 Day Average Volume7.14M
  • Dividend-
  • Dividend Yield-
  • Beta1.00
  • YTD % Change238.82

KEY STATS

  • Open64.57
  • Day High64.63
  • Day Low64.56
  • Prev Close64.55
  • 52 Week High64.70
  • 52 Week High Date04/23/24
  • 52 Week Low6.71
  • 52 Week Low Date05/04/23
  • Market Cap4.233B
  • Shares Out65.55M
  • 10 Day Average Volume7.14M
  • Dividend-
  • Dividend Yield-
  • Beta1.00
  • YTD % Change238.82

RATIOS/PROFITABILITY

  • EPS (TTM)-0.68
  • P/E (TTM)-94.59
  • Fwd P/E (NTM)-38.53
  • EBITDA (TTM)-43.674M
  • ROE (TTM)-12.69%
  • Revenue (TTM)58.876M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-54.66%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/09/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Profile

MORE
Alpine Immune Sciences, Inc. is a clinical-stage biopharmaceutical company, which is engaged in discovering and developing protein-based immunotherapies to treat autoimmune and inflammatory diseases. The Company’s approach includes a proprietary scientific platform that converts native immune system proteins into differentiated, multi-targeted therapeutics. Its ALPN-303 (povetacicept) is a dual antagonist of the B cell activating factor (BAFF) and a proliferation, inducing...
Mitchell Gold M.D.
Executive Chairman of the Board, Chief Executive Officer
Stanford Peng M.D., Ph.D.
President, Head - Research and Development
Paul Rickey CPA
Chief Financial Officer, Senior Vice President, Corporate Secretary
Address
188 East Blaine St., Suite 200
Seattle, WA
98102
United States

Top Peers

SYMBOLLASTCHG%CHG
KRYS
Krystal Biotech Inc
160.85-1.19-0.73%
NUVL
Nuvalent Inc
68.19+0.59+0.87%
MDGL
Madrigal Pharmaceuticals Inc
208.67-9.71-4.45%
BBIO
BridgeBio Pharma Inc
24.92-0.54-2.12%
IBRX
Immunitybio Inc
5.03-0.46-8.36%